Corbus Pharmaceuticals Holdings, Inc. (CRBP) shares are surging more than 256 percent on Friday morning trade after the company announced that the data from the first-in-human clinical study of CRB-701 demonstrated encouraging safety and efficacy in patients with Nectin-4 positive tumors in the first human study.
Corbus Pharma (CRBP) Files $100M Mixed Shelf streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Obesity Clinical Trial Pipeline Insights | 100+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
The prevalence of obesity has been rising since the past few years, which prompts the growing demand for treatment options. The increasing prevalence of Obesity and the growing research and
/PRNewswire/ DelveInsight s Obesity Pipeline Insight – 2022 report provides comprehensive global coverage of available, marketed, and pipeline obesity.